Document and Entity Information
Document and Entity Information - USD ($) | 12 Months Ended | ||
Dec. 31, 2022 | Apr. 17, 2023 | Jun. 30, 2022 | |
Document and Entity Information | |||
Document Type | 10-K | ||
Document Annual Report | true | ||
Document Transition Report | false | ||
Document Period End Date | Dec. 31, 2022 | ||
Entity File Number | 001-41622 | ||
Entity Registrant Name | Distoken Acquisition Corp | ||
Entity Incorporation, State or Country Code | E9 | ||
Entity Tax Identification Number | 00-0000000 | ||
Entity Address, Address Line One | Unit 1006, Block C, Jinshangjun Park | ||
Entity Address, Address Line Two | No. 2 Xiaoba Road, Panlong District | ||
Entity Address, City or Town | Kunming | ||
Entity Address, Country | CN | ||
City Area Code | +86 871 | ||
Local Phone Number | 63624579 | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | No | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Small Business | true | ||
Entity Emerging Growth Company | true | ||
Entity Ex Transition Period | false | ||
ICFR Auditor Attestation Flag | false | ||
Entity Shell Company | true | ||
Entity Public Float | $ 0 | ||
Entity Common Stock, Shares Outstanding | 9,448,000 | ||
Auditor Name | Marcum LLP | ||
Auditor Location | New York, NY | ||
Auditor Firm ID | 688 | ||
Entity Central Index Key | 0001818605 | ||
Current Fiscal Year End Date | --12-31 | ||
Document Fiscal Year Focus | 2022 | ||
Document Fiscal Period Focus | FY | ||
Amendment Flag | false | ||
Units, each consisting of one ordinary share, one redeemable warrant, and one right | |||
Document and Entity Information | |||
Title of 12(b) Security | Units, each consisting of one ordinary share, one redeemable warrant, and one right | ||
Trading Symbol | DISTU | ||
Security Exchange Name | NASDAQ | ||
Ordinary shares | |||
Document and Entity Information | |||
Title of 12(b) Security | Ordinary shares, par value $0.0001 per share | ||
Trading Symbol | DIST | ||
Security Exchange Name | NASDAQ | ||
Redeemable warrants, each warrant entitling the holder to purchase one ordinary share at a price of $11.50 per share | |||
Document and Entity Information | |||
Title of 12(b) Security | Redeemable warrants, each warrant entitling the holder to purchase one ordinary share at a price of $11.50 per share | ||
Trading Symbol | DISTW | ||
Security Exchange Name | NASDAQ | ||
Rights, each right entitling the holder to receive one-tenth of one ordinary share | |||
Document and Entity Information | |||
Title of 12(b) Security | Rights, each right entitling the holder to receive one-tenth of one ordinary share | ||
Trading Symbol | DISTR | ||
Security Exchange Name | NASDAQ |
BALANCE SHEETS
BALANCE SHEETS - USD ($) | Dec. 31, 2022 | Dec. 31, 2021 | ||
Current assets | ||||
Other receivable | $ 28 | $ 28 | ||
Prepaid expenses | 2,000 | |||
Total current assets | 2,028 | 28 | ||
Deferred offering costs | 678,788 | 256,156 | ||
TOTAL ASSETS | 680,816 | 256,184 | ||
Current liabilities | ||||
Accrued expenses | 305 | |||
Accrued offering costs | 297,049 | 27,584 | ||
Advances from Sponsor | 217,462 | 60,445 | ||
Promissory note - Sponsor | 150,000 | 150,000 | ||
TOTAL LIABILITIES | 664,816 | 238,029 | ||
Commitments and contingencies | ||||
SHAREHOLDERS' EQUITY | ||||
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding | ||||
Ordinary shares, $0.0001 par value; 220,000,000 shares authorized; 2,003,000 shares issued and outstanding as of December 31, 2022 and 2021 | [1],[2],[3] | 200 | 200 | |
Additional paid-in capital | 27,028 | 27,028 | ||
Accumulated deficit | (11,228) | (9,073) | ||
TOTAL SHAREHOLDERS' EQUITY | 16,000 | [1],[2],[4] | 18,155 | |
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | $ 680,816 | $ 256,184 | ||
[1] Includes an aggregate of up to 258,000 shares that were subject to forfeiture if the over-allotment option was not exercised in full by the underwriter (see Note 5). On January 26, 2023, the shareholders of the Company approved, through an ordinary resolution, the redesignation of authorized share capital from two classes of ordinary shares (Class A and Class B) to one class of ordinary shares, through a special resolution and related amendments to the memorandum and articles of association. All share and per-share amounts and descriptions have been retrospectively presented (See Notes 7 and 8). On January 30, 2023, the Company effected a share dividend of 0.2 shares for each ordinary share outstanding, resulting in the Sponsor holding 1,725,000 Founder Shares. All share and per-share amounts have been retroactively restated to reflect the share dividend (See Notes 5 and 8). On January 30, 2023, the Company effected a share dividend of 0.2 shares for each ordinary share outstanding, resulting in the Sponsor holding 1,725,000 Founder Shares. All share and per-share amounts have been retroactively restated to reflect the share dividend (See Notes 5 and 8). |
BALANCE SHEETS (Parenthetical)
BALANCE SHEETS (Parenthetical) | Jan. 30, 2023 shares |
Maximum shares subject to forfeiture | 1,725,000 |
Share dividend | 0.2 |
Subsequent Events | |
Share dividend | 0.2 |
Sponsor | Subsequent Events | |
Maximum shares subject to forfeiture | 1,725,000 |
STATEMENTS OF OPERATIONS
STATEMENTS OF OPERATIONS - USD ($) | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | ||
STATEMENTS OF OPERATIONS | |||
Formation and operating costs | $ 2,155 | ||
Net loss | $ (2,155) | ||
Weighted average shares outstanding, basic | [1],[2],[3] | 1,725,000 | 1,773,644 |
Weighted average shares outstanding, diluted | [1],[2],[3] | 1,725,000 | 1,773,644 |
[1] Includes an aggregate of up to 258,000 shares that were subject to forfeiture if the over-allotment option was not exercised in full by the underwriter (see Note 5). On January 26, 2023, the shareholders of the Company approved, through an ordinary resolution, the redesignation of authorized share capital from two classes of ordinary shares (Class A and Class B) to one class of ordinary shares, through a special resolution and related amendments to the memorandum and articles of association. All share and per-share amounts and descriptions have been retrospectively presented (See Notes 7 and 8). On January 30, 2023, the Company effected a share dividend of 0.2 shares for each ordinary share outstanding, resulting in the Sponsor holding 1,725,000 Founder Shares. All share and per-share amounts have been retroactively restated to reflect the share dividend (See Notes 5 and 8). |
STATEMENTS OF OPERATIONS (Paren
STATEMENTS OF OPERATIONS (Parenthetical) | Jan. 30, 2023 shares | Jan. 26, 2023 item | Dec. 31, 2022 shares | Dec. 31, 2021 shares |
STATEMENTS OF OPERATIONS | ||||
Maximum shares subject to forfeiture | shares | 1,725,000 | 258,000 | ||
Share dividend | shares | 0.2 | |||
Number of classes of ordinary shares, redesignation of authorized share capital | item | 2 | |||
Number classes of ordinary shares redesignated | item | 1 |
STATEMENTS OF CHANGES IN SHAREH
STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY - USD ($) | Ordinary shares | Additional Paid-in Capital | Accumulated Deficit | Total | |
Balance at the beginning at Dec. 31, 2020 | $ 182 | $ 27,028 | $ (9,073) | $ 18,137 | |
Balance at the beginning (in shares) at Dec. 31, 2020 | 1,825,000 | ||||
Increase (decrease) in Stockholders' (deficit) equity | |||||
Issuance of Representative Shares | $ 18 | 18 | |||
Issuance of Representative Shares (in shares) | 178,000 | ||||
Balance at the end at Dec. 31, 2021 | $ 200 | 27,028 | (9,073) | 18,155 | |
Balance at the end (in shares) at Dec. 31, 2021 | 2,003,000 | ||||
Increase (decrease) in Stockholders' (deficit) equity | |||||
Issuance of Representative Shares | $ 2,070,000 | ||||
Issuance of Representative Shares (in shares) | 900,000 | ||||
Net income (loss) | (2,155) | $ (2,155) | |||
Balance at the end at Dec. 31, 2022 | [1],[2],[3] | $ 200 | $ 27,028 | $ (11,228) | $ 16,000 |
Balance at the end (in shares) at Dec. 31, 2022 | [1],[2],[3] | 2,003,000 | |||
[1] Includes an aggregate of up to 258,000 shares that were subject to forfeiture if the over-allotment option was not exercised in full by the underwriter (see Note 5). On January 26, 2023, the shareholders of the Company approved, through an ordinary resolution, the redesignation of authorized share capital from two classes of ordinary shares (Class A and Class B) to one class of ordinary shares, through a special resolution and related amendments to the memorandum and articles of association. All share and per-share amounts and descriptions have been retrospectively presented (See Notes 7 and 8). On January 30, 2023, the Company effected a share dividend of 0.2 shares for each ordinary share outstanding, resulting in the Sponsor holding 1,725,000 Founder Shares. All share and per-share amounts have been retroactively restated to reflect the share dividend (See Notes 5 and 8). |
STATEMENTS OF CHANGES IN SHAR_2
STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY (Parenthetical) | Jan. 30, 2023 shares | Jan. 26, 2023 item | Dec. 31, 2022 shares | Dec. 31, 2021 shares |
STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY | ||||
Maximum shares subject to forfeiture | shares | 1,725,000 | 258,000 | ||
Share dividend | shares | 0.2 | |||
Number of classes of ordinary shares, redesignation of authorized share capital | item | 2 | |||
Number classes of ordinary shares redesignated | item | 1 |
STATEMENTS OF CASH FLOWS
STATEMENTS OF CASH FLOWS - USD ($) | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Cash Flows from Operating Activities: | |||
Net loss | $ (2,155) | $ 0 | |
Changes in operating assets and liabilities: | |||
Prepaid expenses | (2,000) | 0 | |
Accrued expenses | 305 | 0 | |
Net cash used in operating activities | (3,850) | 0 | |
Cash Flows from Financing Activities: | |||
Advances from related party | 157,017 | 52,843 | |
Proceeds from promissory note - related party | 0 | 44,731 | |
Payment of offering costs | (153,167) | (97,574) | |
Net cash provided by financing activities | 3,850 | 0 | |
Net change in cash | 0 | 0 | |
Cash - Beginning | 0 | ||
Cash - Ending | 0 | 0 | |
Non-cash investing and financing activities: | |||
Offering costs included in accrued offering costs | $ 297,049 | $ 27,584 | $ 0 |
ORGANIZATION AND PLAN OF BUSINE
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS | 12 Months Ended |
Dec. 31, 2022 | |
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS | |
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS | NOTE 1 — ORGANIZATION AND PLAN OF BUSINESS OPERATIONS Distoken Acquisition Corporation (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on July 1, 2020. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities (“Business Combination”). As of December 31, 2022, the Company had not commenced any operations. All activity for the period from July 1, 2020 (inception) through December 31, 2022 relates to the Company’s formation and the preparation of the initial public offering (“Initial Public Offering”), which closed on February 17, 2023, which is described below. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end. The registration statement for the Company’s Initial Public Offering was declared effective on February 13, 2023. On February 17, 2023, the Company consummated the Initial Public Offering of 6,900,000 units (the “Units” and, with respect to the ordinary shares included in the Units sold, the “Public Shares”), which includes the full exercise by the underwriters of their over-allotment option in the amount of 900,000 Units, at $10.00 per Unit, generating gross proceeds of $69,000,000 which is described in Note 3. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 545,000 units (the “Private Units”) at a price of $10.00 per Private Unit in a private placement (the “Private Placement”) to the Company’s sponsor, Xiaosen Sponsor LLC (the “Sponsor”), generating gross proceeds of $5,450,000, which is described in Note 4. Transaction costs amounted to $4,366,343 consisting of $2,070,000 of cash underwriting discount, $1,185,493 fair value of representative shares, $12,075 fair value of representative warrants, and $1,098,775 of other offering costs. Following the closing of the Initial Public Offering on February 17, 2023, an amount of $70,380,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Units was placed in a trust account (the “Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 180 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. Nasdaq rules provide that the Business Combination must be with one or more target businesses that together have an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding taxes payable on the income earned on the Trust Account) at the time of the agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide its shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The shareholders will be entitled to redeem their shares for a pro rata portion of the amount held in the Trust Account (initially $10.20 per share) as of two business days prior to the completion of a Business Combination, including any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 upon such completion of a Business Combination and, if the Company seeks shareholder approval, it receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the Company. If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5), the ordinary shares included in the Private Units (the “Private Shares”) and any Public Shares purchased in or after the Initial Public Offering in favor of approving a Business Combination and to waive its redemption rights with respect to any such shares in connection with a shareholder vote to approve a Business Combination or seek to sell any shares to the Company in a tender offer in connection with a Business Combination. Additionally, subject to the immediately succeeding paragraph, each public shareholder may elect to redeem their Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against a proposed Business Combination. Notwithstanding the foregoing, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to 15% or more of the Public Shares without the Company’s prior written consent. The Sponsor has agreed (a) to waive its redemption rights with respect to any Founder Shares, Private Shares and Public Shares held by it in connection with the completion of a Business Combination (and not seek to sell its shares to the Company in any tender offer the Company undertakes in connection with a Business Combination) and (b) not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (i) that would affect the ability of holders of Public Shares to convert or sell their shares to the Company in connection with a Business Combination or to modify the substance or timing of the Company’s obligation to redeem 100% of the Public Shares if the Company does not complete a Business Combination within 9 months from the closing of the Initial Public Offering (or up to 18 months from the closing of the Initial Public Offering if the Company extends the period of time to consummate a Business Combination) or (ii) with respect to any other provision relating to shareholders’ rights or pre-initial business combination activity, unless the Company provides the public shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment and (c) that the Founder Shares shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the Sponsor will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the Initial Public Offering if the Company fails to complete its Business Combination. The Company will have until 9 months from the closing of the Initial Public Offering, or until November 17, 2023, to consummate a Business Combination. However, if the Company anticipates that it may not be able to consummate a Business Combination within 9 months, it may, by resolution of the Company’s board of directors if requested by the Sponsor, extend the period of time to consummate a Business Combination up to three times, each by an additional three months (for a total of up to 18 months) (the “Combination Period”), subject to the Sponsor depositing additional funds into the Trust Account. Pursuant to the terms of the Company’s Memorandum and Articles of Association and the Trust Agreement to be entered into between the Company and Continental Stock Transfer & Trust Company on the date of the prospectus, in order for the time available to consummate the Initial Business Combination to be extended, the Sponsor or its affiliates or designees, upon five days advance notice prior to the applicable deadline, must deposit into the Trust Account $690,000 ($0.10 per Unit) for each three month extension, up to an aggregate of $2,070,000 for nine months, on or prior to the date of the applicable deadline. If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than 10 business days thereafter, redeem 100% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (less up to $50,000 of interest to pay dissolution expenses and which interest shall be net of taxes payable), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company’s board of directors, dissolve and liquidate, subject (in each case) to its obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. The Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a third party (other than the Company’s independent auditors) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.20 per Public Share or (2) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of trust assets, in each case net of the interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriter of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent auditors), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statement does not include any adjustments that might result from the outcome of this uncertainty. In February 2022, Russia commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against Russia. The invasion of Ukraine may result in market volatility that could adversely affect the Company’s stock price and its search for a target company. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these financial statements and the specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these financial statements. Going Concern Consideration The Company’s liquidity needs prior to the consummation of the Initial Public Offering were satisfied through the payment of $25,000 from the Sponsor issuance of Founder Shares, loan proceeds from the Sponsor of $150,000 under a promissory note and advances from related party. Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds from the Initial Public Offering and the Private Placement proceeds that are due from the Sponsor. In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, it would repay such loaned amounts at that time. Up to $1,500,000 of such Working Capital Loans may be converted upon completion of a Business Combination into units at a price of $10.00 per unit. Such units would be identical to the Private Units. In connection with the Company’s assessment of going concern considerations in accordance with the authoritative guidance in Financial Accounting Standard Board (“FASB”) Accounting Standards Update (“ASU”) Topic 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the Company currently lacks the liquidity it needs to sustain operations for a reasonable period of time, which is considered to be at least one year from the date that the financial statement is issued as it expects to continue to incur significant costs in pursuit of its acquisition plans. In addition, the Company has until November 17, 2023 to consummate a Business Combination (or August 17, 2024 if the Company extends the period of time to consummate a Business Combination by the full amount of time). It is uncertain that the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by November 17, 2023 (or August 17, 2024 if the Company extends the period of time to consummate a Business Combination by the full amount of time), there will be a mandatory liquidation and subsequent dissolution. Management has determined that mandatory liquidation, should a Business Combination not occur, and an extension not be approved by the shareholders of the Company, and potential subsequent dissolution and the liquidity issue raise substantial doubt about the Company’s ability to continue as a going concern for one year from the date these financial statements are issued. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after November 17, 2023 (or August 17, 2024 if the Company extends the period of time to consummate a Business Combination by the full amount of time). The Company intends to continue to search for and seek to complete a Business Combination before the mandatory liquidation date. The Company is within 12 months of its mandatory liquidation date as of the time of filing of this Annual Report on Form 10-K. |
SUMMARY OF SIGNIFICANT ACCOUNTI
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 12 Months Ended |
Dec. 31, 2022 | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying financial statement is presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the financial statement in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash and cash equivalents as of December 31, 2022 and 2021. Redeemable Share Classification The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, or if there is a shareholder vote or tender offer in connection with the Company’s initial business combination. In accordance with ASC Topic 480-10-S99, “Distinguishing Liabilities from Equity”, the Company classifies Public Shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Public Shares sold as part of the Units in the Initial Public Offering were issued with other freestanding instruments (i.e., Public Warrants and Public Rights) and as such, the initial carrying value of Public Shares classified as temporary equity are the allocated proceeds determined in accordance with ASC Topic 470-20, “Debt With Conversion and Other Options”. The Company recognizes changes in redemption value immediately as it occurs and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital and accumulated deficit. At December 31, 2022 and 2021, there were no ordinary shares subject to possible redemption. Deferred Offering Costs The Company complies with the requirements of the ASC Topic 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A — “Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Initial Public Offering. Offering costs will be allocated to the separable financial instruments issued in the Initial Public Offering based on relative fair value basis, compared to total proceeds received. Offering costs allocated to the Public Shares will be charged to temporary equity and offering costs allocated to Public Warrants (as defined in Note 3) were charged to shareholders’ equity upon the completion of the Initial Public Offering. As of December 31, 2022 and 2021, there were $678,788 and $256,156 of deferred offering costs, respectively, recorded in the accompanying balance sheets. Income Taxes The Company accounts for income taxes under ASC Topic 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statement and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company is considered an exempted Cayman Islands Company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on this account. Net Loss per Share Net loss per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 258,000 ordinary shares that are subject to forfeiture if the over-allotment option is not exercised by the underwriter (see Note 5). At December 31, 2022 and 2021 the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the periods presented. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). Derivative instruments are initially recorded at fair value on the grant date and re-valued at each reporting date, with changes in the fair value reported in the statement of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative assets and liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instruments could be required within 12 months of the balance sheet date. Warrant Instruments The Company will account for the Public, Private, and Representative Warrants issued in connection with the Initial Public Offering and the private placement in accordance with the guidance contained in ASC Topic 815 “Derivatives and Hedging”, whereby under that provision, the warrants that do not meet the criteria for equity treatment must be recorded as liability. Accordingly, the Company evaluated and will classify the warrant instruments as equity in the financial statements after the Initial Public Offering. Recently Issued Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements. |
INITIAL PUBLIC OFFERING
INITIAL PUBLIC OFFERING | 12 Months Ended |
Dec. 31, 2022 | |
INITIAL PUBLIC OFFERING | |
INITIAL PUBLIC OFFERING | NOTE 3 — INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering (“IPO”), the Company sold 6,900,000 Units, which includes the full exercise by the underwriters of their over-allotment option in the amount of 900,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one one |
PRIVATE PLACEMENT
PRIVATE PLACEMENT | 12 Months Ended |
Dec. 31, 2022 | |
PRIVATE PLACEMENT | |
PRIVATE PLACEMENT | NOTE 4 — PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 545,000 Private Units at a price of $10.00 per Private Unit, for an aggregate purchase price of $5,450,000 from the Company in a private placement. Each Private Unit consists of one Private Share, one right (“Private Right”) and one redeemable warrant (“Private Warrant”). Each Private Right entitles the holder thereof to receive one |
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS | 12 Months Ended |
Dec. 31, 2022 | |
RELATED PARTY TRANSACTIONS | |
RELATED PARTY TRANSACTIONS | NOTE 5 — RELATED PARTY TRANSACTIONS Founder Shares On July 8, 2020, the Sponsor paid $25,000 to cover certain offering costs of the Company in consideration for 1,150,000 ordinary shares (the “Founder Shares”). In August 2021, the Company effected a share dividend of 0.25 shares for each Founder Share outstanding, resulting in the Sponsor holding 1,437,500 Founder Shares. On January 30, 2023, the Company effected a share dividend of 0.2 shares for each ordinary share outstanding, resulting in the Sponsor holding 1,725,000 Founder Shares. All share and per-share amounts have been retroactively restated to reflect the share dividend. The Founder Shares include an aggregate of up to 225,000 shares that were subject to forfeiture by the Sponsor to the extent that the underwriter’s over-allotment was not exercised in full or in part, so that the number of Founder Shares will collectively represent 20% of the Company’s issued and outstanding shares (excluding the Private Shares and the Representative Shares, as defined in Note 6) upon the completion of the Initial Public Offering. On January 26, 2023, the shareholders of the Company approved, through an ordinary resolution, the redesignation of authorized share capital from two classes of ordinary shares (Class A and Class B) to one class of ordinary shares, through a special resolution and related amendments to the memorandum and articles of association. All share and per-share amounts and descriptions have been retrospectively presented. The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier of (A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) for 50% of the Founder Shares, if the last reported sale price of the ordinary shares equals or exceeds $12.50 per share (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, (y) for 50% of the Founder Shares, if the last reported sale price of the ordinary shares equals or exceeds $12.50 per share (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period after a Business Combination, or (z) the date following the completion of a Business Combination on which the Company completes a liquidation, merger, amalgamation, share exchange, reorganization or other similar transaction that results in all of the Company’s shareholders having the right to exchange their ordinary shares for cash, securities or other property. Administrative Services Agreement The Company entered into an agreement, commencing on February 15, 2023, to pay the Sponsor or its affiliate up to $10,000 per month for office space, administrative and support services. Upon completion of a Business Combination or its liquidation, the Company will cease paying these monthly fees. As of December 31, 2022 and 2021, the Company did not incur administrative services fees. Advances from Sponsor The advances from Sponsor represents the amounts paid by the Sponsor on behalf of the Company in excess of the limit that can be drawn against the promissory note. Promissory Note — Related Party On July 8, 2020, the Company issued an unsecured promissory note to the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $150,000. The note is non-interest bearing and was payable on the earlier of (i) September 30, 2022 and (ii) the completion of the Initial Public Offering. In November 2022 the note was amended and the note became payable on the earlier of (i) June 30, 2023 and (ii) the completion of the Initial Public Offering. As of December 31, 2022 and 2021, there was $150,000 outstanding under the note. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required. Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of notes may be converted upon completion of a Business Combination into units at a price of $10.00 per unit. Such units would be identical to the Private Units. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of December 31, 2022 and 2021, the Company has no outstanding borrowings under the Working Capital Loans. Related Party Extension Loans As discussed in Note 1, the Company may extend the period of time to consummate a Business Combination up to three times, each by an additional three months (for a total of 18 months to complete a Business Combination). In order to extend the time available for the Company to consummate a Business Combination, the Sponsor or its affiliates or designees must deposit into the Trust Account $690,000 ($0.10 per Public Share) for each three month extension, up to an aggregate of $2,070,000 for nine months, on or prior to the date of the applicable deadline, for each three month extension. Any such payments would be made in the form of a non-interest bearing loan. The terms of the promissory note to be issued in connection with any such loans have not yet been negotiated. If the Company completes a Business Combination, the Company would repay such loaned amounts out of the proceeds of the Trust Account released to the Company. If the Company does not complete a Business Combination, the Company will not repay such loans. The Sponsor and its affiliates or designees are not obligated to fund the Trust Account to extend the time for the Company to complete a Business Combination. |
COMMITMENTS
COMMITMENTS | 12 Months Ended |
Dec. 31, 2022 | |
COMMITMENTS | |
COMMITMENTS | NOTE 6 — COMMITMENTS Registration Rights The holders of the Founder Shares, Representative Shares, Private Units and any units that may be issued on conversion of the Working Capital Loans (and any securities underlying the Private Units or units issued upon conversion of Working Capital Loans) will be entitled to registration rights pursuant to a registration rights agreement. The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45-day option to purchase up to 900,000 additional Units to cover over-allotments at the Initial Public Offering price, less the underwriting discounts and commissions. On February 17, 2023, simultaneously with the closing of the Initial Public Offering, the underwriters elected to fully exercise the over-allotment option to purchase an additional 900,000 Units at a price of $10.00 per Unit. The underwriters were also entitled to a cash underwriting discount of $0.30 per Unit, or $2,070,000 in the aggregate, which was paid upon the closing of the Initial Public Offering. Business Combination Marketing Agreement The Company has engaged I-Bankers Securities, Inc. (“I-Bankers”), the representative of the underwriters in the Initial Public Offering, as an advisor in connection with its Business Combination to assist in holding meetings with the Company shareholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing its securities in connection with its initial Business Combination and assist with press releases and public filings in connection with the Business Combination. The Company will pay I-Bankers a cash fee for such services upon the consummation of its initial business combination in an amount equal to 4.0% of the gross proceeds of the Initial Public Offering (exclusive of any applicable finders’ fees which might become payable). The Company will also pay I-Bankers a cash fee in an amount equal to 1.0% of the gross proceeds of the Initial Public Offering if it introduces the Company to the target business with whom the Company completes its initial Business Combination. |
SHAREHOLDERS' EQUITY
SHAREHOLDERS' EQUITY | 12 Months Ended |
Dec. 31, 2022 | |
SHAREHOLDERS' EQUITY | |
SHAREHOLDERS' EQUITY | NOTE 7 — SHAREHOLDERS’ EQUITY Preference Shares directors will be able to, without shareholder approval, issue preferred shares with voting and other rights that could adversely affect the voting power and other rights of the holders of the ordinary shares and could have anti-takeover effects. At December 31, 2022 and 2021, there were no preference shares issued and outstanding. Ordinary Shares The Company is authorized to issue 220,000,000 ordinary shares, with a par value of $0.0001 per share. Holders of ordinary shares are entitled to one vote for each share. In August 2021, the Company effected a share dividend of 0.25 shares for each founder share outstanding, resulting in the Sponsor holding 1,437,500 Founder Shares. On January 30, 2023, the Company effected a share dividend of 0.2 shares for each ordinary share outstanding, resulting in the Sponsor holding 1,725,000 Founder Shares. At December 31, 2022 and 2021, there were 2,003,000, ordinary shares issued and outstanding, which includes 1,725,000 Founders Shares and 278,000 Representative Shares. As a result of the underwriters’ election to fully exercise their over-allotment option on February 17, 2023, a total of 225,000 Founder Shares and 33,000 representative shares are no longer subject to forfeiture. Rights one-tenth 1/10 If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of rights will not receive any of such funds with respect to their rights, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such rights, and the rights will expire worthless. Further, there are no contractual penalties for failure to deliver securities to the holders of the rights upon consummation of a Business Combination. Additionally, in no event will the Company be required to net cash settle the rights. Accordingly, the rights may expire worthless. Warrants — No warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the ordinary shares issuable upon exercise of the warrants and a current prospectus relating to such ordinary shares. Notwithstanding the foregoing, if a registration statement covering the ordinary shares issuable upon exercise of the Public Warrants is not effective within 60 business days following the consummation of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. Once the Public Warrants become exercisable, the Company may redeem the Public Warrants for redemption: ● in whole and not in part; ● at a price of $0.01 per Public Warrant; ● upon not less than 30 days ’ prior written notice of redemption to each warrant holder; ● if, and only if, the reported last sale price of the ordinary shares equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations), for any 20 trading days within a 30 trading day period commencing after the warrants become exercisable and ending on the third business day prior to the notice of redemption to warrant holders; and ● if, and only if, there is a current registration statement in effect with respect to the ordinary shares underlying such warrants. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of ordinary shares issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Rights or Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Rights and Public Warrants may expire worthless. In addition, if (x) the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the completion of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Public Warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of the Market Value or the Newly Issued Price, and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value or the Newly Issued Price. The Private Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Warrants and the ordinary shares issuable upon the exercise of the Private Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. Representative Shares On July 28, 2020 the Company issued to EarlyBirdCapital and its designees an aggregate of 100,000 ordinary shares for aggregate consideration of $10.00, of which 2,250 were subsequently forfeited in August 2021. In August 2021, the Company also issued to I-Bankers Securities, Inc. and its designees an aggregate of 155,250 ordinary shares at a purchase price of $0.0001 per share, for aggregate consideration of $15.50. On October 28, 2021, the Company issued to EarlyBirdCapital and I-Bankers Securities, Inc. and its designees, 12,132 and 12,868, respectively, ordinary shares at a purchase price of $0.0001 per share, for minimal consideration of $2.50. Of the representative shares, 33,000 are no longer subject to forfeiture due to the underwriters’ exercise of their over-allotment option in full at the Initial Public Offering. Upon issuance, the representative shares were accounted for as deferred offering cost and were charged to shareholders equity upon the Initial Public Offering. The Company estimated the fair value of the 97,750 (net of 2,250 forfeited) representative shares issued on July 28, 2020 to be $2,151 based upon the price of the Founder Shares issued to the Sponsor of $0.022 per share and recorded as deferred offering costs accordingly. The 155,250 representative shares issued on August 23, 2021 and 25,000 representative shares issued on October 28, 2021 had an aggregate fair value using the scenario analysis, of which the stock price input into the founder shares scenario analysis was valued using a binomial lattice, of $1,019,993 ($6.57 per share) and $165,500 ($6.62 per share), respectively, or a total aggregate value of $1,185,493. Accordingly, $1,185,493 were accounted for as offering costs at the closing of the Initial Public Offering. The representative shares are classified as Level 3 at the measurement date due to the use of unobservable inputs including the probability of a business combination, the probability of the initial public offering, and other risk factors. The following table presents the quantitative information regarding market assumptions used in the representative shares valuation: August 23, October 28, 2021 2021 Market price of public stock (1) $ 9.06 $ 9.09 Risk-free rate (2) 0.83 % 1.22 % Dividend yield (3) 0.00 0.00 Volatility (4) 14.5 % 12.5 % (1) As reported by Bloomberg on the Valuation Date (2) Based on the U.S. Treasury rate with a term matching the time to expiration (3) Based on an analysis of the guideline companies and discussions with management (4) Implied volatility calculated using the Black-Scholes formula using the fair value of the warrant. This value is presented for comparison purposes only as it excludes the impact of redemption features. The holders of the representative shares have agreed not to transfer, assign or sell any such shares until the completion of a Business Combination. In addition, the holders have agreed (i) to waive conversion rights (or right to participate in any tender offer) with respect to such shares in connection with the completion of a Business Combination and (ii) to waive their rights to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete a Business Combination within the Combination Period. The representative shares have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the effective date of the registration statement related to the Initial Public Offering pursuant to Rule 5110(g)(1) of the FINRA Manual. Pursuant to FINRA Rule 5110(g)(1), these securities will not be sold during the Initial Public Offering, or sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person for a period of 180 days immediately following the effective date of the registration statement related to the Initial Public Offering or commencement of sales of the Initial Public Offering, except to any underwriter and selected dealer participating in the Initial Public Offering and their bona fide officers or partners. Representative Warrants In addition, the Company entered into a separate warrant agreement with I-Banker Securities, Inc. (referred as “I-Bankers”, the “Representative” of the Underwriters) to issue Representative Warrants exercisable to purchase 172,500 ordinary shares at a price of $12.00 per share, subject to adjustment. The representative warrants were issued at the closing of the Initial Public Offering for consideration of $100. The Company accounted for the representative warrants as an offering cost of the Initial Public Offering, with a corresponding credit to shareholders’ equity. The representative warrants had an estimated fair value of $12,075 based on the third party valuation using the binomial lattice model of $0.07 per warrant. The Representative Warrants may be exercised for cash or on a cashless basis, at the holder’s option, at any time during the period commencing on the later of the first anniversary of the effective date of the registration statement of which the prospectus forms a part and the closing of the Initial Business Combination and terminating on the fifth anniversary of such effectiveness date. Notwithstanding anything to the contrary, I-Bankers will agree that neither it nor its designees will be permitted to exercise the warrants after the five-year anniversary of the effective date of the registration statement. The Representative Warrants and such shares to be purchased pursuant to the Representative Warrants have been deemed compensation by FINRA and are therefore subject to a lock-up period of 180 days immediately following the date of the effectiveness of the registration statement of which the prospectus forms a part pursuant to FINRA Rule 5110(g)(1). Pursuant to FINRA Rule 5110(g)(1), these securities may not be sold, transferred, assigned, pledged or hypothecated or the subject of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person for a period of 180 days immediately following the effective date of the registration statement of which the prospectus forms a part except to any underwriter and selected dealer participating in the Initial Public Offering and their bona fide officers or partners. |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 12 Months Ended |
Dec. 31, 2022 | |
SUBSEQUENT EVENTS | |
SUBSEQUENT EVENTS | NOTE 8 — SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statement was issued. Based upon this review, other than as disclosed below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statement. On January 26, 2023, the shareholders of the Company approved, through an ordinary resolution, the redesignation of authorized share capital from two classes of ordinary shares (Class A and Class B) to ordinary shares and, through a special resolution, related amendments to the memorandum and articles of association. All share and per-share amounts and descriptions have been retrospectively presented. On January 30, 2023, the Company effected a share dividend of 0.2 shares for each ordinary share outstanding, resulting in the Sponsor holding 1,725,000 Founder Shares. All share and per-share amounts have been retroactively restated to reflect the share dividend. As disclosed within the notes, on February 17, 2023, the Company consummated the Initial Public Offering of 6,900,000, which includes the full exercise by the underwriters of their over-allotment option in the amount of 900,000 Units, at $10.00 per Unit, generating gross proceeds of $69,000,000. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 545,000 private units at a price of $10.00 per Private Unit in a private placement to the Company’s Sponsor, generating gross proceeds of $5,450,000. On March 27, 2023, the Sponsor transferred $1,372,977 to the operating account as the funds to be held outside of the trust. As of the date of this financial statement filing, there is $821,821 available outside of the trust to be used for working capital purposes. On March 28, 2023, the Company paid the $150,000 outstanding under the Promissory Note – Related party and the advances from related party which were owed as of that date, which totaled $251,969. On March 28, 2023, the Company announced that, commencing on March 30, 2023, the Company’s units issued in its Initial Public Offering, which consist of one ordinary share of the Company, par value $0.0001 per share, one right of the Company, with each right entitling the holder thereof to receive one |
SUMMARY OF SIGNIFICANT ACCOUN_2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 12 Months Ended |
Dec. 31, 2022 | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | |
Basis of Presentation | Basis of Presentation The accompanying financial statement is presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. |
Emerging Growth Company | Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. |
Use of Estimates | Use of Estimates The preparation of the financial statement in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash and cash equivalents as of December 31, 2022 and 2021. |
Redeemable Share Classification | Redeemable Share Classification The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, or if there is a shareholder vote or tender offer in connection with the Company’s initial business combination. In accordance with ASC Topic 480-10-S99, “Distinguishing Liabilities from Equity”, the Company classifies Public Shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Public Shares sold as part of the Units in the Initial Public Offering were issued with other freestanding instruments (i.e., Public Warrants and Public Rights) and as such, the initial carrying value of Public Shares classified as temporary equity are the allocated proceeds determined in accordance with ASC Topic 470-20, “Debt With Conversion and Other Options”. The Company recognizes changes in redemption value immediately as it occurs and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital and accumulated deficit. At December 31, 2022 and 2021, there were no ordinary shares subject to possible redemption. |
Deferred Offering Costs | Deferred Offering Costs The Company complies with the requirements of the ASC Topic 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A — “Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Initial Public Offering. Offering costs will be allocated to the separable financial instruments issued in the Initial Public Offering based on relative fair value basis, compared to total proceeds received. Offering costs allocated to the Public Shares will be charged to temporary equity and offering costs allocated to Public Warrants (as defined in Note 3) were charged to shareholders’ equity upon the completion of the Initial Public Offering. As of December 31, 2022 and 2021, there were $678,788 and $256,156 of deferred offering costs, respectively, recorded in the accompanying balance sheets. |
Income Taxes | Income Taxes The Company accounts for income taxes under ASC Topic 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statement and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company is considered an exempted Cayman Islands Company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented. |
Concentration of Credit Risk | Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on this account. |
Net Loss per Share | Net Loss per Share Net loss per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 258,000 ordinary shares that are subject to forfeiture if the over-allotment option is not exercised by the underwriter (see Note 5). At December 31, 2022 and 2021 the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the periods presented. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. |
Derivative Financial Instruments | Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). Derivative instruments are initially recorded at fair value on the grant date and re-valued at each reporting date, with changes in the fair value reported in the statement of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative assets and liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instruments could be required within 12 months of the balance sheet date. |
Warrant Instruments | Warrant Instruments The Company will account for the Public, Private, and Representative Warrants issued in connection with the Initial Public Offering and the private placement in accordance with the guidance contained in ASC Topic 815 “Derivatives and Hedging”, whereby under that provision, the warrants that do not meet the criteria for equity treatment must be recorded as liability. Accordingly, the Company evaluated and will classify the warrant instruments as equity in the financial statements after the Initial Public Offering. |
Recently Issued Accounting Standards | Recently Issued Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements. |
SHAREHOLDERS' EQUITY (Tables)
SHAREHOLDERS' EQUITY (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
SHAREHOLDERS' EQUITY | |
Schedule of quantitative information regarding market assumptions used in representative shares valuation | August 23, October 28, 2021 2021 Market price of public stock (1) $ 9.06 $ 9.09 Risk-free rate (2) 0.83 % 1.22 % Dividend yield (3) 0.00 0.00 Volatility (4) 14.5 % 12.5 % (1) As reported by Bloomberg on the Valuation Date (2) Based on the U.S. Treasury rate with a term matching the time to expiration (3) Based on an analysis of the guideline companies and discussions with management (4) Implied volatility calculated using the Black-Scholes formula using the fair value of the warrant. This value is presented for comparison purposes only as it excludes the impact of redemption features. |
ORGANIZATION AND PLAN OF BUSI_2
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS (Details) | 12 Months Ended | |||
Feb. 17, 2023 USD ($) $ / shares shares | Dec. 31, 2022 USD ($) $ / shares shares | Dec. 31, 2021 USD ($) | Jan. 30, 2023 shares | |
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS | ||||
gross proceeds | $ 69,000,000 | |||
Shares Issued, Price Per Share | $ / shares | $ 10 | $ 10.20 | ||
Number of shares in a unit | shares | 1 | |||
Number of shares issuable per warrant | shares | 1 | |||
Exercise price of warrants | $ / shares | $ 11.50 | |||
Number of warrants to purchase shares issued | shares | 258,000 | 1,725,000 | ||
Price of warrant | $ / shares | $ 10 | |||
Transaction Costs | $ 4,366,343 | |||
Underwriting fees | 2,070,000 | |||
Other offering costs | 678,788 | $ 256,156 | ||
Fair value of class A shares issued to underwriters | $ 1,185,493 | |||
Condition for future Business Combination use of proceeds percentage | 50 | |||
Investments, maximum maturity term | 180 days | |||
Investments held in Trust Account | $ 50,000 | |||
Working capital deficit | 1,500,000 | |||
Deposit in trust account | 690,000 | |||
Aggregate consideration | $ 2,070,000 | 18 | ||
Share Price | $ / shares | $ 10.20 | |||
Promissory note - Sponsor | $ 150,000 | $ 150,000 | ||
Condition for future business combination threshold Percentage Ownership | 100 | |||
Condition for future business combination threshold Net Tangible Assets | $ 5,000,001 | |||
Redemption period upon closure | 9 months | |||
Private Placement Units | ||||
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS | ||||
Exercise price of warrants | $ / shares | $ 11.50 | |||
Number of warrants to purchase shares issued | shares | 1 | |||
Fair value of class A shares issued to underwriters | $ 12,075 | |||
Public Warrants | ||||
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS | ||||
Sale of Units, net of underwriting discounts (in shares) | shares | 0.10 | |||
Number of shares issuable per warrant | shares | 1 | |||
Price of warrant | $ / shares | $ 10.20 | |||
Initial Public Offering | ||||
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS | ||||
Sale of Units, net of underwriting discounts (in shares) | shares | 6,900,000 | |||
gross proceeds | $ 70,380,000 | $ 5,450,000 | ||
Condition for future Business Combination use of proceeds percentage | 80 | |||
Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent) | 100% | |||
Aggregate consideration | $ 25,000 | |||
Share Price | $ / shares | $ 0.10 | |||
Due to the Sponsor for certain reimbursable expenses | $ 150,000 | |||
Redemption limit percentage without prior consent | 15 | |||
Private Placement | ||||
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS | ||||
Shares Issued, Price Per Share | $ / shares | $ 10 | |||
Number of shares issuable per warrant | shares | 0.10 | |||
Number of warrants to purchase shares issued | shares | 545,000 | |||
Price of warrant | $ / shares | $ 10 | |||
Proceeds allocated to Public Warrants | $ 5,450,000 | |||
Private Placement | Private Placement Units | ||||
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS | ||||
Price of warrant | $ / shares | $ 10 | |||
Over-allotment option | ||||
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS | ||||
Sale of Units, net of underwriting discounts (in shares) | shares | 900,000 | |||
Number of shares issuable per warrant | shares | 900,000 | |||
Related Party Loans | ||||
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS | ||||
Price of warrant | $ / shares | $ 10 | |||
Other offering costs | $ 1,098,775 | |||
Sponsor | Private Placement | Private Placement Units | ||||
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS | ||||
Number of warrants to purchase shares issued | shares | 545,000 |
SUMMARY OF SIGNIFICANT ACCOUN_3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($) | 12 Months Ended | ||
Feb. 17, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Cash equivalents | $ 0 | $ 0 | |
Investments held in Trust Account | 50,000 | ||
Transaction Costs | 4,366,343 | ||
Underwriting fees | 2,070,000 | ||
Other offering costs | 678,788 | 256,156 | |
Unrecognized tax benefits | 0 | 0 | |
Unrecognized tax benefits accrued for interest and penalties | 0 | $ 0 | |
Federal depository insurance coverage | $ 250,000 | ||
Shares subject to forfeiture | 258,000 | ||
Share Price | $ 10.20 | ||
Net proceeds from IPO | $ 69,000,000 | ||
Initial Public Offering | |||
Share Price | $ 0.10 | ||
Net proceeds from IPO | $ 70,380,000 | $ 5,450,000 |
INITIAL PUBLIC OFFERING (Detail
INITIAL PUBLIC OFFERING (Details) | Feb. 17, 2023 $ / shares shares |
INITIAL PUBLIC OFFERING | |
Number of shares in a unit | 1 |
Number of shares per warrant | 1 |
Exercise price of warrants | $ / shares | $ 11.50 |
Public Warrants | |
INITIAL PUBLIC OFFERING | |
Number of units sold | 0.10 |
Number of shares per warrant | 1 |
Private Warrants | |
INITIAL PUBLIC OFFERING | |
Number of shares per warrant | 1 |
Initial Public Offering | |
INITIAL PUBLIC OFFERING | |
Number of units sold | 6,900,000 |
Price per share | $ / shares | $ 10 |
Over-allotment option | |
INITIAL PUBLIC OFFERING | |
Number of units sold | 900,000 |
Number of shares per warrant | 900,000 |
PRIVATE PLACEMENT (Details)
PRIVATE PLACEMENT (Details) - USD ($) | Feb. 17, 2023 | Jan. 30, 2023 | Dec. 31, 2022 |
PRIVATE PLACEMENT | |||
Number of warrants to purchase shares issued | 1,725,000 | 258,000 | |
Price of warrants | $ 10 | ||
Number of shares in a unit | 1 | ||
Number of shares per warrant | 1 | ||
Exercise price of warrant | $ 11.50 | ||
Private Placement Units | |||
PRIVATE PLACEMENT | |||
Number of warrants to purchase shares issued | 1 | ||
Number of warrants in a unit | 1 | ||
Exercise price of warrant | $ 11.50 | ||
Public Warrants [Member] | |||
PRIVATE PLACEMENT | |||
Price of warrants | $ 10.20 | ||
Number of shares per warrant | 1 | ||
Private Placement | |||
PRIVATE PLACEMENT | |||
Number of warrants to purchase shares issued | 545,000 | ||
Price of warrants | $ 10 | ||
Aggregate purchase price | $ 5,450,000 | ||
Number of shares per warrant | 0.10 | ||
Private Placement | Private Placement Units | |||
PRIVATE PLACEMENT | |||
Price of warrants | $ 10 |
RELATED PARTY TRANSACTIONS - Fo
RELATED PARTY TRANSACTIONS - Founder Shares (Details) - USD ($) | 1 Months Ended | 12 Months Ended | ||||||
Feb. 17, 2023 | Jan. 30, 2023 | Jan. 26, 2023 | Jul. 08, 2020 | Aug. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | Mar. 28, 2023 | |
Related Party Transactions | ||||||||
Number of shares issued | 900,000 | 900,000 | ||||||
Common stock, par value (per share) | $ 0.0001 | $ 0.0001 | ||||||
Aggregate consideration | $ 2,070,000 | $ 18 | ||||||
Shares subject to forfeiture | 258,000 | |||||||
Subsequent Events | ||||||||
Related Party Transactions | ||||||||
Common stock, par value (per share) | $ 0.0001 | |||||||
Founder Shares | ||||||||
Related Party Transactions | ||||||||
Number of shares issued | 1,150,000 | |||||||
Aggregate consideration | $ 25,000 | |||||||
Share dividend | 0.25 | |||||||
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) | $ 12.50 | |||||||
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | 20 days | |||||||
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences | 30 days | |||||||
Founder Shares | Subsequent Events | ||||||||
Related Party Transactions | ||||||||
Shares subject to forfeiture | 225,000 | |||||||
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders | 20% | |||||||
Founder Shares | Sponsor | ||||||||
Related Party Transactions | ||||||||
Aggregate number of shares owned | 1,437,500 | |||||||
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders | 50% | |||||||
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of a Business Combination | 1 year | |||||||
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) | $ 12.50 | |||||||
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | 20 days | |||||||
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | 30 days | |||||||
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences | 150 days | |||||||
Founder Shares | Sponsor | Subsequent Events | ||||||||
Related Party Transactions | ||||||||
Number of shares issued | 1,725,000 | |||||||
Share dividend | 0.2 |
RELATED PARTY TRANSACTIONS - Ad
RELATED PARTY TRANSACTIONS - Additional Information (Details) - USD ($) | 12 Months Ended | ||||
Feb. 15, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Jul. 08, 2020 | |
Related Party Transactions | |||||
Promissory note - Sponsor | $ 150,000 | $ 150,000 | |||
Price of warrant | $ 10 | ||||
Investments held in Trust Account | $ 50,000 | ||||
Share Price | $ 10.20 | ||||
Promissory Note with Related Party | |||||
Related Party Transactions | |||||
Borrowing capacity | $ 150,000 | ||||
Outstanding balance | $ 150,000 | $ 150,000 | |||
Administrative Support Agreement | |||||
Related Party Transactions | |||||
Expenses per month | $ 10,000 | ||||
Related Party Loans | |||||
Related Party Transactions | |||||
Loan conversion agreement warrant | $ 1,500,000 | ||||
Price of warrant | $ 10 | ||||
Related Party Loans | Working capital loans warrant | |||||
Related Party Transactions | |||||
Outstanding balance of related party note | $ 0 | ||||
Related Party Extension Loans | |||||
Related Party Transactions | |||||
Investments held in Trust Account | $ 690,000 | ||||
Share Price | $ 0.10 | ||||
Aggregate share issued value | $ 2,070,000 | ||||
Extension period | 3 months |
COMMITMENTS (Details)
COMMITMENTS (Details) | 12 Months Ended | ||
Feb. 17, 2023 $ / shares shares | Dec. 31, 2022 USD ($) item $ / shares shares | Dec. 31, 2021 USD ($) | |
Schedule Of Commitments [Line Items] | |||
Maximum number of demands for registration of securities | item | 3 | ||
Underwriting fees | $ 2,070,000 | ||
Underwriting cash discount per unit (in percentage) | 4 | ||
Aggregate consideration | $ 2,070,000 | $ 18 | |
Number of shares issued | shares | 900,000 | 900,000 | |
Purchase price per share | $ / shares | $ 10 | $ 10.20 | |
Initial Public Offering | |||
Schedule Of Commitments [Line Items] | |||
Underwriting cash discount per unit | $ / shares | $ 0.30 | ||
Aggregate consideration | $ 25,000 | ||
Underwriter cash discount | $ 2,070,000 |
SHAREHOLDERS' EQUITY - Preferen
SHAREHOLDERS' EQUITY - Preference Shares (Details) - $ / shares | Dec. 31, 2022 | Dec. 31, 2021 |
SHAREHOLDERS' EQUITY | ||
Preference shares, shares authorized | 1,000,000 | 1,000,000 |
Preference shares, par value (in dollars per share) | $ 0.0001 | $ 0.0001 |
Preference shares, shares issued | 0 | 0 |
Preference shares, shares outstanding | 0 | 0 |
SHAREHOLDERS' EQUITY - Ordinary
SHAREHOLDERS' EQUITY - Ordinary Shares (Details) | Mar. 28, 2023 $ / shares | Feb. 17, 2023 shares | Jan. 30, 2023 shares | Jan. 26, 2023 item | Dec. 31, 2022 Vote $ / shares shares | Dec. 31, 2021 $ / shares shares | Aug. 31, 2021 shares |
SHAREHOLDERS' EQUITY | |||||||
Number of classes of ordinary shares, redesignation of authorized share capital | item | 2 | ||||||
Number classes of ordinary shares redesignated | item | 1 | ||||||
Ordinary shares, shares authorized | 220,000,000 | 220,000,000 | |||||
Ordinary shares, par value (in dollars per share) | $ / shares | $ 0.0001 | $ 0.0001 | |||||
Ordinary shares, votes per share | Vote | 1 | ||||||
Share dividend | 0.2 | ||||||
Ordinary shares, shares outstanding | 2,003,000 | 2,003,000 | |||||
Ordinary shares, shares issued | 2,003,000 | 2,003,000 | |||||
Representative Shares | |||||||
SHAREHOLDERS' EQUITY | |||||||
Ordinary shares, shares outstanding | 278,000 | ||||||
Subsequent Events | |||||||
SHAREHOLDERS' EQUITY | |||||||
Number of classes of ordinary shares, redesignation of authorized share capital | item | 2 | ||||||
Number classes of ordinary shares redesignated | item | 1 | ||||||
Ordinary shares, par value (in dollars per share) | $ / shares | $ 0.0001 | ||||||
Share dividend | 0.2 | ||||||
Subsequent Events | Representative Shares | Over-allotment option | |||||||
SHAREHOLDERS' EQUITY | |||||||
Number of shares no longer subject to forfeiture | 33,000 | ||||||
Founder Shares | |||||||
SHAREHOLDERS' EQUITY | |||||||
Share dividend | 0.25 | ||||||
Ordinary shares, shares outstanding | 1,725,000 | ||||||
Founder Shares | Subsequent Events | Over-allotment option | |||||||
SHAREHOLDERS' EQUITY | |||||||
Number of shares no longer subject to forfeiture | 225,000 | ||||||
Founder Shares | Sponsor | |||||||
SHAREHOLDERS' EQUITY | |||||||
Ordinary shares, shares outstanding | 1,437,500 | ||||||
Founder Shares | Sponsor | Subsequent Events | |||||||
SHAREHOLDERS' EQUITY | |||||||
Ordinary shares, shares outstanding | 1,725,000 |
SHAREHOLDERS' EQUITY - Rights (
SHAREHOLDERS' EQUITY - Rights (Details) | 12 Months Ended |
Dec. 31, 2022 USD ($) shares | |
SHAREHOLDERS' EQUITY | |
Number of ordinary shares for each right | shares | 0.1 |
Additional consideration required to be paid by a holder of rights in order to receive its additional shares | $ 0 |
Contractual penalties for failure to deliver securities to the holders of the rights | $ 0 |
SHAREHOLDERS' EQUITY - Warrants
SHAREHOLDERS' EQUITY - Warrants (Details) | 12 Months Ended |
Dec. 31, 2022 D $ / shares | |
Public Warrants | |
SHAREHOLDERS' EQUITY | |
Public Warrants exercisable term after the completion of a Business Combination | 30 days |
Public Warrants exercisable term from the closing of the Initial Public Offering | 12 months |
Public Warrants expiration term | 5 years |
Threshold period for registration statement to be effective after which warrants can be exercised on a cashless basis | 60 days |
Redemption price per Public Warrant (in dollars per share) | $ 0.01 |
Minimum threshold written notice period for redemption of Public Warrants | 30 days |
Share redemption trigger price for redemption of Public Warrants (in dollars per share) | $ 18 |
Threshold trading days for redemption of Public Warrants | 20 days |
Threshold consecutive trading days for redemption of Public Warrants | D | 30 |
Threshold number of business days before sending notice of redemption to warrant holders | 3 days |
Threshold issue price for capital raising purposes in connection with the closing of a Business Combination | $ 9.20 |
Percentage of aggregate gross proceeds on total equity proceeds | 60% |
Threshold trading days for calculating volume weighted average trading price | 20 days |
Adjustment of exercise price of Public Warrants based on Market Value or the Newly Issued Price (as a percent) | 115% |
Adjustment of redemption trigger price based on Market Value or the Newly Issued Price (as a percent) | 180% |
Private Warrants | |
SHAREHOLDERS' EQUITY | |
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of a Business Combination | 30 days |
SHAREHOLDERS' EQUITY - Quantita
SHAREHOLDERS' EQUITY - Quantitative Information Regarding Market Assumptions Used in Representative Shares Valuation (Details) - $ / shares | Oct. 28, 2021 | Aug. 23, 2021 | |
SHAREHOLDERS' EQUITY | |||
Market price of public stock | [1] | $ 9.09 | $ 9.06 |
Risk-free rate | [2] | 1.22% | 0.83% |
Dividend yield | [3] | 0% | 0% |
Volatility | [4] | 12.50% | 14.50% |
[1] As reported by Bloomberg on the Valuation Date Based on the U.S. Treasury rate with a term matching the time to expiration Based on an analysis of the guideline companies and discussions with management Implied volatility calculated using the Black-Scholes formula using the fair value of the warrant. This value is presented for comparison purposes only as it excludes the impact of redemption features. |
SHAREHOLDERS' EQUITY - Represen
SHAREHOLDERS' EQUITY - Representative Shares and Representative Warrants (Details) - USD ($) | 1 Months Ended | 12 Months Ended | |||||
Feb. 17, 2023 | Oct. 28, 2021 | Aug. 23, 2021 | Jul. 28, 2020 | Aug. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | |
SHAREHOLDERS' EQUITY | |||||||
Number of shares issued | 900,000 | 900,000 | |||||
Aggregate consideration | $ 2,070,000 | $ 18 | |||||
Purchase price per share | $ 10 | $ 10.20 | |||||
Fair value per share | $ 10.20 | ||||||
Representative Shares | |||||||
SHAREHOLDERS' EQUITY | |||||||
Aggregate consideration | $ 100 | ||||||
Estimated fair value | $ 12,075 | ||||||
Aggregate fair value of shares issued | $ 1,185,493 | ||||||
Fair value per share | $ 0.07 | ||||||
Fair value of shares accounted for as offering costs | $ 1,185,493 | ||||||
Representative Shares | Over-allotment option | Subsequent Events | |||||||
SHAREHOLDERS' EQUITY | |||||||
Number of shares no longer subject to forfeiture | 33,000 | ||||||
Representative Shares | EarlyBirdCapital and its designees | |||||||
SHAREHOLDERS' EQUITY | |||||||
Number of shares issued | 12,132 | 100,000 | |||||
Aggregate consideration | $ 10 | ||||||
Number of shares forfeited | 2,250 | ||||||
Purchase price per share | $ 0.022 | ||||||
Number of shares issued, net of forfeited shares | 97,750 | ||||||
Estimated fair value | $ 2,151 | ||||||
Representative Shares | I-Bankers Securities, Inc. and its designees | |||||||
SHAREHOLDERS' EQUITY | |||||||
Number of shares issued | 12,868 | 155,250 | 155,250 | 172,500 | |||
Aggregate consideration | $ 15.50 | ||||||
Purchase price per share | $ 0.0001 | $ 12 | |||||
Aggregate fair value of shares issued | $ 1,019,993 | ||||||
Fair value per share | $ 6.57 | ||||||
Representative Shares | EarlyBirdCapital and I-Bankers Securities, Inc. and its designees | |||||||
SHAREHOLDERS' EQUITY | |||||||
Number of shares issued | 25,000 | ||||||
Aggregate consideration | $ 2.50 | ||||||
Purchase price per share | $ 0.0001 | ||||||
Aggregate fair value of shares issued | $ 165,500 | ||||||
Fair value per share | $ 6.62 |
SUBSEQUENT EVENTS (Details)
SUBSEQUENT EVENTS (Details) | Mar. 28, 2023 USD ($) $ / shares | Mar. 27, 2023 USD ($) | Feb. 17, 2023 USD ($) $ / shares shares | Jan. 30, 2023 shares | Jan. 26, 2023 item | Dec. 31, 2022 $ / shares shares | Dec. 31, 2021 $ / shares shares | Aug. 31, 2021 shares |
SUBSEQUENT EVENTS | ||||||||
Number of classes of ordinary shares, redesignation of authorized share capital | item | 2 | |||||||
Share dividend | 0.2 | |||||||
Ordinary shares, shares outstanding | 2,003,000 | 2,003,000 | ||||||
Common stock, par value (per share) | $ / shares | $ 0.0001 | $ 0.0001 | ||||||
Exercise price of warrant | $ / shares | $ 11.50 | |||||||
Initial Public Offering | ||||||||
SUBSEQUENT EVENTS | ||||||||
Number of units sold | 6,900,000 | |||||||
Price per Unit | $ / shares | $ 10 | |||||||
Over-allotment option | ||||||||
SUBSEQUENT EVENTS | ||||||||
Number of units sold | 900,000 | |||||||
Founder Shares | ||||||||
SUBSEQUENT EVENTS | ||||||||
Share dividend | 0.25 | |||||||
Ordinary shares, shares outstanding | 1,725,000 | |||||||
Founder Shares | Sponsor | ||||||||
SUBSEQUENT EVENTS | ||||||||
Ordinary shares, shares outstanding | 1,437,500 | |||||||
Subsequent Events | ||||||||
SUBSEQUENT EVENTS | ||||||||
Number of classes of ordinary shares, redesignation of authorized share capital | item | 2 | |||||||
Share dividend | 0.2 | |||||||
Outstanding amount in trust account used for working capital | $ | $ 821,821 | |||||||
Common stock, par value (per share) | $ / shares | $ 0.0001 | |||||||
Class of each right entitling the holder to receive ordinary share upon consummation of initial business combination | $ / shares | 0.1 | |||||||
Exercise price of warrant | $ / shares | $ 11.50 | |||||||
Subsequent Events | Promissory Note with Related Party | ||||||||
SUBSEQUENT EVENTS | ||||||||
Amount outstanding, Promissory Note - Related Party | $ | $ 150,000 | |||||||
Expenses incurred and paid | $ | $ 251,969 | |||||||
Subsequent Events | Initial Public Offering | ||||||||
SUBSEQUENT EVENTS | ||||||||
Number of units sold | 6,900,000 | |||||||
Price per Unit | $ / shares | $ 10 | |||||||
Gross proceeds from Initial Public Offering | $ | $ 69,000,000 | |||||||
Subsequent Events | Over-allotment option | ||||||||
SUBSEQUENT EVENTS | ||||||||
Number of units sold | 900,000 | |||||||
Subsequent Events | Sponsor | ||||||||
SUBSEQUENT EVENTS | ||||||||
Fund transferred to operating account | $ | $ 1,372,977 | |||||||
Subsequent Events | Sponsor | Private Placement | ||||||||
SUBSEQUENT EVENTS | ||||||||
Number of units sold | 545,000 | |||||||
Price per Unit | $ / shares | $ 10 | |||||||
Gross proceeds from private placement | $ | $ 5,450,000 | |||||||
Subsequent Events | Founder Shares | Sponsor | ||||||||
SUBSEQUENT EVENTS | ||||||||
Ordinary shares, shares outstanding | 1,725,000 |